DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus

New test aims to identify patients that may benefit from precision treatment LOS ANGELES, June 9, 2022 /PRNewswire/ -- DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE or lupus). The IFN-1 Test supports the...

Click to view original post